Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-13 Option Award |
2025-03-17 8:54 pm |
N/A 2035-03-12 |
Opus Genetics Inc. | IRD | Zaremba Rabourn Amy SVP of Finance |
39,500 | $0 | 153,468 (Direct) |
View |
| 2025-02-04 Tax Withholding |
2025-02-06 4:37 pm |
N/A N/A |
Opus Genetics Inc. | IRD | Zaremba Rabourn Amy SVP of Finance |
8,190 | $1.14 | 74,468 (Direct) |
View |
| 2024-01-18 Option Award |
2024-01-22 6:01 pm |
N/A 2034-01-17 |
Ocuphire Pharma Inc. | OCUP | Zaremba Rabourn Amy SVP of Finance |
100,000 | $0 | 142,658 (Direct) |
View |
| 2024-01-10 Tax Withholding |
2024-01-12 4:17 pm |
N/A N/A |
Ocuphire Pharma Inc. | OCUP | Zaremba Rabourn Amy SVP of Finance |
3,950 | $3.265 | 42,658 (Direct) |
View |
| 2023-01-10 Option Award |
2023-01-12 5:30 pm |
N/A 2033-01-09 |
Ocuphire Pharma Inc. | OCUP | Zaremba Rabourn Amy SVP of Finance |
116,520 | $0 | 116,520 (Direct) |
View |
| 2022-01-28 Option Award |
2022-02-01 4:23 pm |
N/A 2032-01-27 |
Ocuphire Pharma Inc. | OCUP | Zaremba Rabourn Amy VP of Finance |
50,000 | $0 | 50,000 (Direct) |
View |
| 2020-11-11 Option Award |
2020-11-16 6:31 pm |
N/A 2030-11-11 |
Ocuphire Pharma Inc. | OCUP | Zaremba Rabourn Amy VP of Finance |
75,000 | $0 | 75,000 (Direct) |
View |
Ownership |
2020-11-16 6:26 pm |
N/A 2030-06-03 |
Ocuphire Pharma Inc. | OCUP | Zaremba Rabourn Amy VP of Finance |
0 | $0 | 21,130 (Direct) |
View |